HAEM5:Volunteer Assignments and Opportunities

WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (4th Edition) Content

Disease (5th Edition)	Page Type	Author (5th Edition) (Note: please indicate trainees in parentheses)	Date Assigned to Author (5th Edition)	Target Completion Date (5th Edition)	Content Status (5th Edition)(Pending or Complete)	Date Completed by Author (5th Edition)	Associate Editor	Date of Last Editor Review (5th Edition)	Notes (5th Edition)	Correlated Prior Disease Name (4th Edition)	Correlated Prior Author (4th Edition)	Content Status (4th Edition)(Pending or Complete)	Date of Last Editor Review (4th Edition)	Notes (4th Edition)
CHAPTER 2 (MYELOID PROLIFERATIONS AND NEOPLASMS)
Clonal haematopoiesis	Disease						Fabiola Quintero-Rivera (FQR)			NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Clonal cytopenias of undetermined significance	Disease						FQR			NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Chronic myeloid leukaemia	Disease						FQR			Chronic Myeloid Leukemia (CML), BCR-ABL1 Positive	Jack Reid, MD (University of California, Irvine) Mark Evans, MD (University of California, Irvine) Fabiola Quintero-Rivera, MD (University of California, Irvine)	Complete	Date page was created
Chronic neutrophilic leukaemia	Disease						FQR			Chronic Neutrophilic Leukemia (CNL)	Anamaria Munteanu, MD, Ph.D**, Harbor-UCLA Medical Center, Joseph J. Merlo Jr, MD. Ph.D**, Ashion Analytics, Fabiola Quintero-Rivera, University of California Irvine **contributed equally	Complete	Date page was created
Chronic eosinophilic leukaemia	Disease						FQR			Chronic Eosinophilic Leukemia, Not Otherwise Specified	Chelsea D. Kramish; Daynna J.Wolff	complete/pending faculty review
Polycythaemia vera	Disease						FQR			Polycythemia Vera (PV)	Gokce A. Toruner, MD, PhD UT MD Anderson Cancer Center	Complete
Essential thrombocythaemia	Disease						FQR			Essential Thrombocythemia (ET)	Rebecca Smith, PhD, Director, Genetics Associates, Nashville, TN	Complete
Primary myelofibrosis	Disease						FQR			Primary Myelofibrosis (PMF)	T. Niroshi Senaratne, UCLA	Complete	8/4/2020 before submission
Juvenile myelomonocytic leukaemia	Disease						FQR			Juvenile Myelomonocytic Leukemia (JMML)	Sarah Rapisardo, PhD, FACMG | Assistant Professor, Pathology Associate Director | Division of Molecular Pathology, Genetics and Genomics Duke University Health System Clinical Laboratories	PENDING importing content and reference formatting		FQR has emailed SR several times, last 4/20/22
Myeloproliferative neoplasm, NOS	Disease						FQR			Myeloproliferative Neoplasm (MPN), Unclassifiable	Thomas Lee, MD, PhD, University of California, Los Angeles	Complete
Cutaneous mastocytosis	Disease						FQR			Cutaneous Mastocytosis	S. Shawn Liu, MD, PhD and Thuy Phung, MD, PhD	Complete
Systemic mastocytosis	Disease						FQR			Systemic Mastocytosis	Abdullah Osme, MD, University Hospitals Cleveland Medical Center, Case Western Reserve University Shashi Shetty, Ph.D. FACMG, FCCMG, University Hospitals Cleveland Medical Center, Case Western Reserve University	Complete
Mast cell sarcoma	Disease						FQR			Mast Cell Sarcoma	Jordan Lowery, MD and Thuy Phung, MD, PhD Department of Pathology, University of South Alabama, Mobile, AL	Complete
Myelodysplastic neoplasm with low blasts and 5q deletion	Disease						FQR			Myelodysplastic Syndrome (MDS) with Isolated del(5q)	Xiaolin Hu, Ph.D; Teresa Smolarek, Ph.D, FACMG	Complete
Myelodysplastic neoplasm with low blasts and SF3B1 mutation	Disease						FQR			NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Myelodysplastic neoplasm with biallelic TP53 inactivation	Disease	Eric McGinnis (assigned to new 5th edition page - FQR please follow-up to confirm)					FQR			NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Myelodysplastic neoplasm with low blasts	Disease						FQR			NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Myelodysplastic neoplasm, hypoplastic	Disease						FQR			NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Myelodysplastic neoplasm with increased blasts	Disease						FQR			Myelodysplastic Syndrome (MDS) with Excess Blasts	Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center	Complete
Childhood myelodysplastic neoplasm with low blasts	Disease						FQR			Refractory Cytopenia of Childhood	Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center	Complete
Childhood myelodysplastic neoplasm with increased blasts	Disease						FQR			Refractory Cytopenia of Childhood	Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center	Complete
Chronic myelomonocytic leukaemia	Disease						FQR			Chronic Myelomonocytic Leukemia (CMML)	Linsheng Zhang, MD, PhD	Complete
Myelodysplastic/myeloproliferative neoplasm with neutrophilia	Disease						FQR			Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative	Linsheng Zhang, MD, PhD	Complete
Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis	Disease						FQR			Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)	Anamaria Munteanu, MD, Ph.D, Harbor-UCLA Medical Center, Fabiola Quintero-Rivera, University of California Irvine	Complete	Date page was created
Myelodysplastic/myeloproliferative neoplasm, NOS	Disease						FQR			Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable	Ruth MacKinnon PhD Victorian Cancer Cytogenetics Service Melbourne, Australia	Complete
Acute promyelocytic leukaemia with PML::RARA fusion	Disease						Jennelle Hodge (JH)/ Malini Sathanoori (MS)			Acute Promyelocytic Leukemia (APL) with PML-RARA	Yiming Zhong, Ph.D., Megan Piazza, Ph.D., and Shashi Shetty, Ph.D.	Complete	03/01/2021-MS (re-review)
Acute myeloid leukaemia with RUNX1::RUNX1T1 fusion	Disease						JH_MS			Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1	Christine Bryke, MD Beth Israel Deaconess Medical Center, Boston, MA	Complete	04/26/2021-MS (re-review)
Acute myeloid leukaemia with CBFB::MYH11 fusion	Disease						JH_MS			Acute Myeloid Leukemia (AML) with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	Christine Bryke, MD Beth Israel Deaconess Medical Center, Boston, MA	Complete	03/01/2021-MS (re-review)
Acute myeloid leukaemia with DEK::NUP214 fusion	Disease						JH_MS			Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214	Jennelle C. Hodge, PhD, FACMG	Complete	02/24/2021-MS (re-review)
Acute myeloid leukaemia with RBM15::MRTFA fusion	Disease						JH_MS			Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1	Jennelle C. Hodge, PhD, FACMG	Complete
Acute myeloid leukaemia with BCR::ABL1 fusion	Disease						JH_MS			Acute Myeloid Leukemia (AML) with BCR-ABL1	Kay Weng Choy MBBS, Monash Medical Centre	Complete
Acute myeloid leukaemia with KMT2A rearrangement	Disease						JH_MS			Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3	Megan Piazza, Ph.D., Yiming Zhong, Ph.D., Shashi Shetty, Ph.D.	Complete	03/01/2021-MS (re-review)
Acute myeloid leukaemia with MECOM rearrangement	Disease						JH_MS			Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM	Gordana Raca MD PhD, University of Southern California, Los Angeles	Complete		Need permission for figure? Update WHO?
Acute myeloid leukaemia with NUP98 rearrangement	Disease						JH_MS			NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Acute myeloid leukaemia with NPM1 mutation	Disease						JH_MS			Acute Myeloid Leukemia (AML) with Mutated NPM1	Xinjie Xu, PhD, FACMG	Complete		Add WHO reference
Acute myeloid leukaemia with CEBPA mutation	Disease						JH_MS			Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA	Paul Defazio, MSc, Monash Health	Complete
Acute myeloid leukaemia, myelodysplasia-related	Disease						JH_MS			Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes	Fei Yang, MD, FACMG Oregon Health & Science University	Complete
Acute myeloid leukaemia with other defined genetic alterations	Disease						JH_MS			NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Acute myeloid leukaemia with minimal differentiation	Disease						JH_MS			Acute Myeloid Leukemia (AML) with Minimal Differentiation	Celeste Eno, PhD, Cedars Sinai Medical Center, Los Angeles, Fabiola Quintero-Rivera, MD, FACMG, University of California Irvine	Complete
Acute myeloid leukaemia without maturation	Disease						JH_MS			Acute Myeloid Leukemia (AML) without Maturation	Jennelle C. Hodge, PhD, FACMG	Complete
Acute myeloid leukaemia with maturation	Disease						JH_MS			Acute Myeloid Leukemia (AML) with Maturation	Jennelle C. Hodge, PhD, FACMG	Complete
Acute basophilic leukaemia	Disease						JH_MS			Acute Basophilic Leukemia	Ashwini Yenamandra PhD FACMG	Complete
Acute myelomonocytic leukaemia	Disease						JH_MS			Acute Myelomonocytic Leukemia	Fei Yang, MD, FACMG Oregon Health & Science University	Complete
Acute monocytic leukaemia	Disease						JH_MS			Acute Monoblastic and Monocytic Leukemia	Fei Yang, MD, FACMG Oregon Health & Science University	Complete
Acute erythroid leukaemia	Disease						JH_MS			Pure Erythroid Leukemia	Ashwini Yenamandra PhD FACMG	Complete
Acute megakaryoblastic leukaemia	Disease						JH_MS			Acute Megakaryoblastic Leukemia (AMKL)	Fei Yang, MD, FACMG Oregon Health & Science University	Complete
Myeloid sarcoma	Disease						JH_MS			Myeloid Sarcoma	Yalda Naeini, MD, School of Medicine at University of California Los Angeles Fabiola Quintero-Rivera, MD, FACMG, School of Medicine at University of California Irvine	Complete
RESOLVE 4th edition AML-Related NON-WHO entities content	Acute Myeloid Leukemia (AML) with Mutated FLT3 + Acute Myeloid Leukemia (AML) with NUP214-ABL1 + Acute Myeloid Leukemia (AML) with t(4;12)(q12;p13); CHIC2-ETV6	ISSUE - FIX
Myeloid neoplasm post cytotoxic therapy	Disease						JH_MS			Therapy-Related Myeloid Neoplasms	Shawn A. Silver, DO, Shashi Shetty, Ph.D.			Check reference format
Myeloid neoplasms associated with germline predisposition	Disease	ISSUE - FIX					JH_MS
Myeloid proliferations associated with Down syndrome	Disease						JH_MS			MERGE 3 PAGES --> Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome + Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome + Myeloid Leukemia Associated with Down Syndrome	Linda D Cooley, MD, MBA, Children's Mercy Hospital, Kansas City, MO	Complete (all three pages)
Myeloid/lymphoid neoplasm with PDGFRA rearrangement	Disease						FQR			Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement	Jay Alden, DO	Complete
Myeloid/lymphoid neoplasm with PDGFRB rearrangement	Disease						FQR			Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement	Christopher Sullivan, MD, MPH and Daynna J. Wolff, PhD	Complete
Myeloid/lymphoid neoplasm with FGFR1 rearrangement	Disease						FQR			Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement	Yanna Ding, MD PhD	Complete
Myeloid/lymphoid neoplasm with JAK2 rearrangement	Disease	ISSUE- FIX Resolve Non-WHO entities					FQR			Myeloid/Lymphoid Neoplasms with PCM1-JAK2 + consider a non-WHO page Myeloid/Lymphoid Neoplasms with ETV6-JAK2 (Myeloid/Lymphoid Neoplasms with ETV6-JAK2 - Compendium of Cancer Genome Aberrations (ccga.io)) + another non-WHO page Myeloid/Lymphoid Neoplasms with BCR-JAK2 (Myeloid/Lymphoid Neoplasms with BCR-JAK2 - Compendium of Cancer Genome Aberrations (ccga.io) ) - both non-WHO pages are authored by trainee Lauren Crowson-Hindman and Daynna Wolff	Jessica Snider, M.D. and Daynna J. Wolff, PhD + non-WHO pages by trainee Lauren Crowson-Hindman and Daynna Wolff	Complete
Myeloid/lymphoid neoplasm with FLT3 rearrangement	Disease	ISSUE - FIX					FQR			Acute Myeloid Leukemia (AML) with Mutated FLT3 (HAEM4:Acute Myeloid Leukemia (AML) with Mutated FLT3 ) ???No prior content on this page??? I don't think this is a WHO entity from the 4th edition.
Myeloid/lymphoid neoplasm with ETV6::ABL1 fusion	Disease						FQR			NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes	Disease						FQR			NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Mixed-phenotype acute leukaemia with BCR::ABL1 fusion	Disease	Tracy Tucker, PhD, FCCMG					JH_MS
Mixed-phenotype acute leukaemia with KMT2A rearrangement	Disease	Tracy Tucker, PhD, FCCMG					JH_MS
Acute leukaemia of ambiguous lineage with other defined genetic alterations	Disease						JH_MS
Mixed-phenotype acute leukaemia, B/myeloid	Disease	Priyatharsini Nirmalanantham, MD and Shashi Shetty, PhD					JH_MS
Mixed-phenotype acute leukaemia, T/myeloid	Disease	Narsis Attar, MD, PhD, Fabiola Quintero-Rivera, MD University of California, Irvine					JH_MS
Mixed-phenotype acute leukaemia, rare types	Disease	Elicia Goodale, MD, Medical University of South Carolina Daynna Wolff, PhD, Medical University of South Carolina					JH_MS
Acute leukaemia of ambiguous lineage, NOS	Disease						JH_MS
Acute undifferentiated leukaemia	Disease	Amelia Nakanishi, MD and Shashi Shetty, PhD					JH_MS
CHAPTER 3 (HISTIOCYTIC/DENRITIC CELL NEOPLASMS)
Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm	Disease						Greg Corboy (GC)
Blastic plasmacytoid dendritic cell neoplasm	Disease	Hao Liu, MD and Daynna J. Wolff, PhD					GC
Langerhans cell histiocytosis	Disease	Dr Malaika Perchard BSci(MedSci), MBBS, FRACP, FRCPA, (Paediatric Haematologist) Pathology Queensland					GC
Langerhans cell sarcoma	Disease	Dr Malaika Perchard BSci(MedSci), MBBS, FRACP, FRCPA, (Paediatric Haematologist) Pathology Queensland					GC
Indeterminate dendritic cell tumour	Disease						GC
Interdigitating dendritic cell sarcoma	Disease						GC
Juvenile xanthogranuloma	Disease						GC
Erdheim-Chester disease	Disease						GC
Rosai-Dorfman Disease	Disease						GC
ALK-positive histiocytosis	Disease						GC
Histiocytic sarcoma	Disease	Marie-France Gagnon, MD, Mayo Clinic, Xinjie Xu, PhD FACMG, Mayo Clinic					GC
CHAPTER 4 (B-CELL LYMPHOID PROLIFERATIONS AND LYMPHOMAS)
Reactive B-cell rich lymphoid proliferations that can mimic lymphoma	Disease						GC
IgG4-related disease	Disease						GC
Unicentric Castleman disease	Disease						GC
Idiopathic multicentric Castleman disease	Disease						GC
KSHV/HHV8-associated multicentric Castleman disease	Disease	Sudha Arumugam, MD					GC
B-lymphoblastic leukaemia/lymphoma	Disease						Holli Drendel (HD)
B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy	Disease	Afia Hasnain, MBBS, PhD; Yassmine Akkari, PhD, FACMG					HD
B-lymphoblastic leukaemia/lymphoma with hypodiploidy	Disease	Ashwini Yenamandra PhD FACMG Lisa Smith PhD FACMG Yassmine Akkari PhD FACMG					HD
B-lymphoblastic leukaemia/lymphoma with iAMP21	Disease	Holli M. Drendel, PhD, FACMGG, Carolinas Pathology Group, Charlotte					HD
B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion	Disease	Afia Hasnain, MBBS, PhD; Yassmine Akkari, PhD, FACMG					HD
B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features	Disease	Mark G. Evans, MD, University of California, Irvine Fabiola Quintero-Rivera, MD, University of California, Irvine					HD
B lymphoblastic leukaemia/lymphoma with KMT2A rearrangement	Disease	Yassmine Akkari Nicolas Millan					HD
B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion	Disease	Marilena Melas, PhD; Yassmine Akkari, PhD, FACMG Cancer Category/Type B-Lymphoblastic Leukemia/Lymphoma					HD
B-lymphoblastic leukaemia/lymphoma with ETV6::RUNX1-like features	Disease						HD
B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion	Disease	Binu Porath, PhD. Vanderbilt University Medical Center, Nashville, TN Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO					HD
B lymphoblastic leukaemia/lymphoma with IGH::IL3 fusion	Disease	Binu Porath, PhD. Vanderbilt University Medical Center, Nashville, TN Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO					HD
B lymphoblastic leukaemia/lymphoma with TCF3::HLF fusion	Disease						HD
B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations	Disease						HD
B-lymphoblastic leukaemia/lymphoma, NOS	Disease						HD
RESOLVE 4th edition ALL-Related NON-WHO entities content	B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4 + B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6 + B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements + B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions + B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19) + B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)	ISSUE - FIX
Monoclonal B-cell lymphocytosis	Disease						Shivani Golem (SG)
Chronic lymphocytic leukaemia/small lymphocytic lymphoma	Disease	Jamie Nagy, PhD, University of Iowa Honey Reddi, PhD					SG
Hairy cell leukaemia	Disease	*Snehal Patel, MD, PhD					SG
Splenic marginal zone lymphoma	Disease	*Snehal Patel, MD, PhD					SG
Splenic diffuse red pulp small B-cell lymphoma	Disease	*Snehal Patel, MD, PhD					SG
Splenic B-cell lymphoma/leukaemia with prominent nucleoli	Disease	*Snehal Patel, MD, PhD					SG
Lymphoplasmacytic lymphoma	Disease	Kapitolina Semenova, MD, Jack Reid, MD, Fabiola Quintero-Rivera, MD Departments of Pathology, Laboratory Medicine, and *Pediatrics, Division of Genetic and Genomic Medicine, University of California, Irvine (UCI)					SG
Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue	Disease						SG
Primary cutaneous marginal zone lymphoma	Disease						SG
Nodal marginal zone lymphoma	Disease	Andrew Ly, DO and Shivani Golem, PhD, FACMG					SG
Paediatric nodal marginal zone lymphoma	Disease	* Kathleen M. Schieffer, PhD * Ruthann Pfau, PhD					SG
In situ follicular B-cell neoplasm	Disease	Rachel D. Burnside, PhD, MBA, FACMGG					SG
Follicular lymphoma	Disease	Ruthann Pfau, PhD, FACMG, Nationwide Children's Hospital Rachel D. Burnside, PhD, MBA, FACMG, University of Florida					SG
Paediatric-type follicular lymphoma	Disease	*Kathleen M. Schieffer, PhD *Ruthann Pfau, PhD, FACMG					SG
Duodenal-type follicular lymphoma	Disease						SG
Primary cutaneous follicle centre lymphoma	Disease	Linlin Gao, MD, PhD and Shivani Golem, PhD, FACMG					SG
In situ mantle cell neoplasm	Disease	Rina Kansal, MD; Versiti Blood Center of Wisconsin					SG
Mantle cell lymphoma	Disease	* Mahsa Khanlari, MD * Zhenya Tang, MD, PhD The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas					SG
Leukaemic non-nodal mantle cell lymphoma	Disease						SG
Transformations of indolent B-cell lymphomas	Disease						SG
Diffuse large B-cell lymphoma, NOS	Disease	Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center					GC
T-cell/histiocyte-rich large B-cell lymphoma	Disease						GC
Diffuse large B-cell lymphoma / high grade B-cell lymphoma with MYC and BCL2 rearrangements	Disease	Kate Berry, MBBS, BBus (Hons), Pathology Queensland					GC
ALK-positive large B-cell lymphoma	Disease	Manando Nakasaki, MD, PhD (University of California, Irvine) Fabiola Quintero-Rivera, MD, FACMG (University of California, Irvine)					GC
Large B-cell lymphoma with IRF4 rearrangement	Disease	*Afia Hasnain, MBBS, PhD					GC
High grade B-cell lymphoma with 11q aberrations	Disease	Lauren Shealy, MD, Medical University of South Carolina Daynna Wolff, PhD, Medical University of South Carolina					GC
Lymphomatoid granulomatosis	Disease						GC
EBV-positive diffuse large B-cell lymphoma	Disease						GC
Diffuse large B-cell lymphoma associated with chronic inflammation	Disease						GC
Fibrin-associated large B-cell lymphoma	Disease						GC
Fluid overload-associated large B-cell lymphoma	Disease						GC
Plasmablastic lymphoma	Disease	Mark Evans, MD (University of California, Irvine) Fabiola Quintero-Rivera, MD (University of California, Irvine)					GC
Primary large B-cell lymphoma of immune-privileged sites	Disease	Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center					GC
Primary cutaneous diffuse large B-cell lymphoma, leg type	Disease						GC
Intravascular large B-cell lymphoma	Disease	Kate Berry, MBBS, BBus (Hons), Pathology Queensland					GC
Primary mediastinal large B-cell lymphoma	Disease						GC
Mediastinal grey zone lymphoma	Disease						GC
High-grade B-cell lymphoma, NOS	Disease	Aiko Otsubo, PhD, Indiana University					GC
Burkitt lymphoma	Disease	Becky Leung, MBBS (Hons), BSc, Pathology Queensland					GC
Primary effusion lymphoma	Disease						GC
KSHV/HHV8-positive diffuse large B-cell lymphoma	Disease						GC
KSHV/HHV8-positive germinotropic lymphoproliferative disorder	Disease						GC
Hyperplasias arising in immune deficiency/dysregulation	Disease						GC
Polymorphic lymphoproliferative disorders arising in immune deficiency / dysregulation	Disease	Anna Shestakova, MD, PhD, Fellow, University of Utah/ARUP Laboratories Fabiola Quintero-Rivera, MD, Professor, University of California Irvine (UCI)					GC
EBV-positive mucocutaneous ulcer	Disease						GC
Lymphomas arising in immune deficiency / dysregulation	Disease						GC
Inborn error of immunity-associated lymphoid proliferations and lymphomas	Disease						GC
Classic Hodgkin lymphoma	Disease	Patricia V. Hernandez, M.D., Washington University School of Medicine					GC
Nodular lymphocyte predominant Hodgkin lymphoma	Disease						GC
Cold agglutinin disease	Disease						SG
IgM monoclonal gammopathy of undetermined significance	Disease						SG
Non-IgM monoclonal gammopathy of undetermined significance	Disease						SG
Monoclonal gammopathy of renal significance	Disease						SG
Immunoglobulin-related (AL) amyloidosis	Disease	Heather E. Williams, PhD, MS, PgD, ErCLG					SG
Monoclonal immunoglobulin deposition disease	Disease	Chen Yang, MD, PhD, University of Michigan					SG
Mu heavy chain disease	Disease						SG
Gamma heavy chain disease	Disease	Manisha Brahmbhatt-Sutariya Asst. Professor, Dept. of Pathology and Human Anatomy Technical Supervisor, Clinical Genetics Laboratory Loma Linda University, Medical Center, CA					SG
Alpha heavy chain disease	Disease						SG
Plasmacytoma	Disease						SG
Plasma cell myeloma / multiple myeloma	Disease	*Huan Mo, MD, MS *Zhenya Tang, MD, PhD The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas					SG
Plasma cell neoplasms with associated paraneoplastic syndrome	Disease	Sohini Anand, MBBS Tharanga Niroshini Senaratne, PhD					SG
CHAPTER 5 (T-CELL AND NK-CELL LYMPHOID PROLIFERATIONS AND LYMPHOMAS)
Kikuchi-Fujimoto disease	Disease						Sumi Kitahara (SK)
Autoimmune lymphoproliferative syndrome	Disease						SK
Indolent T-lymphoblastic proliferation	Disease						SK
T-lymphoblastic leukaemia / lymphoma, NOS	Disease						HD
Early T-precursor lymphoblastic leukaemia / lymphoma	Disease	Fei Yang, MD, FACMG, Kaiser Permanente Northwest					HD
T-prolymphocytic leukaemia	Disease						SK
T-large granular lymphocytic leukaemia	Disease	*Michelle Don, MD, MS					SK
NK-large granular lymphocytic leukaemia	Disease	Michelle Don, MD					SK
Adult T-cell leukaemia/lymphoma	Disease	Prasad R. Kopparapu, PhD and Ferrin C. Wheeler, PhD, FACMG Vanderbilt University Medical Center					SK
Sezary syndrome	Disease	Madison E. Hannay, DO, Medical University of South Carolina Tingting Barrett, MD, Medical University of South Carolina Daynna J. Wolff, PhD, Medical University of South Carolina					SK
Aggressive NK-cell leukaemia	Disease	Shanelle De Lancy, MD, Shashirekha Shetty, PhD					SK
Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder	Disease						SK
Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder	Disease						SK
Mycosis fungoides	Disease	Jane Scribner, MD and Daynna J. Wolff, PhD					SK
Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Lymphomatoid papulosis	Disease						SK
Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma	Disease	Theresa Spivey, MD, Shashirekha Shetty, PhD					SK
Subcutaneous panniculitis-like T-cell lymphoma	Disease						SK
Primary cutaneous gamma/delta T-cell lymphoma	Disease						SK
Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma	Disease						SK
Primary cutaneous peripheral T-cell lymphoma, NOS	Disease						SK
Indolent T-cell lymphoma of the gastrointestinal tract	Disease	Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD					SK
Indolent NK-cell lymphoproliferative disorder of the gastrointestinal tract	Disease						SK
Enteropathy-associated T-cell lymphoma	Disease	*Derick Okwan-Duodu, MD, PhD *Sumire Kitahara, MD					SK
Monomorphic epitheliotropic intestinal T-cell lymphoma	Disease	Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD					SK
Intestinal T-cell lymphoma, NOS	Disease	Derick Okwan MD, PhD (Stanford Medicine, CA) Sumire Kitahara MD (Cedars-Sinai, CA)					SK
Hepatosplenic T-cell lymphoma	Disease	*Michelle Don, MD, MS					SK
ALK-positive anaplastic large cell lymphoma	Disease						SK
ALK-negative anaplastic large cell lymphoma	Disease	Miguel Gonzalez Mancera, MD Sumire Kitahara, MD Cedars-Sinai, Los Angeles, CA					SK
Breast implant-associated anaplastic large cell lymphoma	Disease	Derick Okwan-Duodu, MD, PhD; Sumire Kitahara, MD Cedars-Sinai Medical Center					SK
Nodal TFH cell lymphoma, angioimmunoblastic-type	Disease	* Sara Akhavanfard, M.D., Ph.D. * Ruthann Pfau, Ph.D., FACMG					SK
Nodal TFH cell lymphoma, follicular-type	Disease						SK
Nodal TFH cell lymphoma, NOS	Disease	Hans Magne Hamnvåg, MD Kamran Mirza, MD, PhD					SK
Peripheral T-cell lymphoma, NOS	Disease						SK
EBV-positive nodal T- and NK-cell lymphoma	Disease						SK
Extranodal NK/T-cell lymphoma	Disease						SK
Severe mosquito bite allergy	Disease						SK
Hydroa vacciniforme lymphoproliferative disorder	Disease						SK
Systemic chronic active EBV disease	Disease						SK
Systemic EBV-positive T-cell lymphoma of childhood	Disease	*Lisa A. Lansdon, PhD & Linda D. Cooley, MD, MBA					SK
CHAPTER 6 (STROMA-DERIVED NEOPLASMS OF LYMPHOID TISSUES)
Follicular dendritic cell sarcoma	Disease	Anna Heimes Dillon, MD and Shivani Golem, PhD, FACMG					GC
EBV-positive inflammatory follicular dendritic cell sarcoma	Disease						GC
Fibroblastic reticular cell tumour	Disease						GC
Intranodal palisaded myofibroblastoma	Disease						GC
Littoral cell angioma	Disease						GC
Splenic hamartoma	Disease						GC
Sclerosing angiomatoid nodular transformation (SANT) of spleen	Disease						GC
CHAPTER 7 (GENETIC TUMOUR SYNDROMES)
Fanconi anaemia	Disease						NA
Bloom syndrome	Disease						NA
Ataxia-telangiectasia syndrome	Disease						NA
RASopathies	Disease						NA